A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/20 (2006.01) A61K 38/17 (2006.01) A61K 38/44 (2006.01)
Patent
CA 2615887
This invention provides methods and compositions used for reducing the Myocardial Infarct (MI) size in diabetic subjects exhibiting the haptoglobin (Hp) 2 allele. Specifically, the invention relates to reduction of MI in diabetic subjects carrying the Hp-2 allele by reducing the oxidative sterss in these subjects following ischemia-reperfusion injury.
La présente invention se rapporte à des méthodes et à des compositions destinées à réduire la taille de l'infarctus du myocarde chez des sujets diabétiques présentant l'allèle de l'haptoglobine (Hp) 2. Plus précisément, l'invention concerne la réduction de l'infarctus du myocarde chez des sujets diabétiques porteurs de l'allèle Hp-2, par la réduction du stress oxydatif chez lesdits sujets à la suite d'une lésion liée d'ischémie-reperfusion.
Berkowitz Noah
Levy Andrew
Berkowitz Noah
Levy Andrew
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Rappaport Family Institute For Research In The Medical Sciences
LandOfFree
Reduction in myocardial infarction size does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reduction in myocardial infarction size, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reduction in myocardial infarction size will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1650704